Previous Page  20 / 25 Next Page
Information
Show Menu
Previous Page 20 / 25 Next Page
Page Background

Page 73

conferenceseries

.com

Volume 8, Issue 3(Suppl)

J Allergy Ther, an open access journal

ISSN: 2155-6121

Allergy-Clinical Immunology 2017

September 07-08, 2017

September 07-08, 2017 | Edinburgh, Scotland

ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY

11

th

International Conference on

Decrypt the link of the ongoing leak:Acase of idiopathic systemic capillary leak syndrome (Clarkson’s

disease): A case report

Ryan Aliñab, Mary Anne Cruz

and

Rosa Ong

Chinese General Hospital and Medical Center Manila, Philippines

Introduction:

Idiopathic systemic capillary leak syndrome (ISCLS) or Clarkson’s disease is an extremely rare and fatal condition

characterized by episodic attacks of capillary leakage of plasma from the intravascular to the interstitial space resulting in

hypotension, hemoconcentration, and hypoalbuminemia. If not diagnosed early, it has a high morbidity and mortality rate.

Treatment is supportive, focusing on aggressive but cautious fluid resuscitation together with pharmacologic treatment to

control capillary leakage. Each attack varies in severity and can be life features threatening due possible organ failure secondary

to poor perfusion.

Aim:

This study aims to raise awareness of the main presentation of ISCLS, to explain the possible pathophysiology, clinical

course of the disease, to differentiate with other causes of distributive shock and to present the latest recommendations on

treatment and prevention based on limited evidences available.

Case Presentation:

Our case is a 38 year old male who initially experienced flu-like symptoms such as body malaise, headache

and generalized weakness. He was previously treated as a case of community-acquired pneumonia, high risk, admitted at

intensive care unit. He claimed to have a history of allergy to seafood and medications such as paracetamol and antibiotics.

In the emergency room, patient was hypotensive and was managed as a case of anaphylactic shock. He was hydrated, started

on inotropic agents and corticosteroid. Work-up tests revealed severe hemoconcentration, hypoalbuminemia, metabolic

acidosis, and hyperkalemia. No focus of infection was documented. He remained stable with negative fluid balance until the

fourth hospital day, when he suddenly developed pulmonary edema. Patient was managed with diuretics, airway support and

inotropics. Patient condition improved and was discharged on 10th hospital day.

Conclusion:

ISCLS is a rare and fatal disease that has a high mortality if not detected early. Therefore, prompt recognition is

important in the effective management of the disease and its complications.

ryanoalinab@yahoo.com

J Allergy Ther 2017, 8:3(Suppl)

DOI: 10.4172/2155-6121-C1-006